Published • loading... • Updated
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
- WuXi Biologics has been included in the 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index for its sustainability efforts and advancing sustainability.
- The Dow Jones Best-in-Class indexes select companies ranking in the top 10% for long-term economic, environmental, and social performance among large global and emerging market companies, based on S&P Global's Corporate Sustainability Assessment.
- WuXi Biologics ranked in the top 1% globally within its industry in the 2025 Corporate Sustainability Assessment and was named to the S&P Global Sustainability Yearbook for the fourth consecutive year.
- Dr. Chris Chen, CEO of WuXi Biologics, said the recognition reflects the company's dedication to and improvements in environmental, social, and governance areas.
Insights by Ground AI
22 Articles
22 Articles
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
SHANGHAI, May 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued efforts and exceptional performance in advancing sustainability, the Company has been included in the…
Coverage Details
Total News Sources22
Leaning Left5Leaning Right2Center9Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 31%
C 56%
13%
Factuality
To view factuality data please Upgrade to Premium
